81
Pharmaceutical Product Development (PPDI)
Negotiating the modern-day labyrinth of regulations to get new drug from the lab through experiments and into the marketplace would make even the original Messrs. Merck and Lilly consider other careers. That's where Pharmaceutical Product Development comes in. The Wilmington (N.C.)-based company -- run by a duo formerly at drug giant Glaxo -- employs a global network of 8,400 employees in 27 countries who help coordinate clinical trials for drug manufacturers at a lower cost than if they did the trials themselves. Business has been booming: Annual sales have risen by an average 19% over the past three years to $1.04 billion, with profits up an average 54% during that same period to $131.5 million. PPD's latest contract: A deal with PDL BioPharma to do comprehensive molecular profiling to help the Fremont (Calif.) company come up with new compounds.
Company Info |
|
| 2005 Rank | NR |
| Market Value* ($ Millions) | 4,160.8 |
| Sales* ($ Millions) | 1,092.4 |
| Sales Growth (3-yr. avg. annual) |
19.1 % |
| Profits* ($ Millions) | 137.7 |
| Profit Growth (3-yr. avg. annual) | 54.3 % |
| Return on Inv. Capital (3-yr.) | 13.8 % |
| Share Price 12-Mo. Hi/Lo | 41/22 |
| Share Price As of 4/28/06 | 36 |
| Return on Equity | 17.0 % |
| P/E Ratio | 31 |
| No. of Employees | 8,000 |
| Industry | Life Sciences Tools & Services |
| CURRENT MARKET INFO | PPDI > |
| COMPANY WEB SITE > | |
| Location | Wilmington, N.C. |
| Phone | 910 251-0081 |
*Trailing 12 months
Stock price data as of 4/28/06
DATA: Standard & Poor's Compustat
Related Articles
Can Healthcare Keep Sizzling?
The Drugmaker’s Man Friday
A Drug R&D Firm Worth Discovering
Company Snapshot
Pharmaceutical Product Development, along with its subsidiaries, provides drug discovery and development services, post-approval expertise, and compound partnering programs as a contract research organization. It operates in two segments, Discovery Sciences and Development. The Discovery Sciences segment offers biomarker discovery and patient sample analysis, compound partnering programs, and preclinical services, including preclinical program design, specialized preclinical oncology and diabetes research models, toxicology consulting, laboratory services, and technical writing and regulatory submissions. The Development segment provides development services, such as preclinical programs, Phase I to Phase IV clinical development services, and laboratory services. The company also offers post-approval support services, such as product launch services, patient compliance programs, disease registry programs, medical information, product safety and pharmacovigilance, Phase IV monitored studies, and prescription-to-over-the-counter programs. It serves pharmaceutical, biotechnology, medical device, and government organizations in the U.S., Europe, and Latin America. The company was founded in 1985 and has its headquarters in Wilmington, N.C.
Data provided by 
